The immune contexture of primary and metastatic human tumours

被引:114
作者
Giraldo, Nicolas A. [1 ,2 ,3 ]
Becht, Etienne [1 ,2 ,3 ]
Remark, Romain [1 ,2 ,3 ]
Damotte, Diane [1 ,2 ,3 ,4 ]
Sautes-Fridman, Catherine [1 ,2 ,3 ]
Fridman, Wolf H. [1 ,2 ,3 ]
机构
[1] INSERM, UMRS872, Cordeliers Res Ctr, Immune Microenvironm & Tumours Lab, Paris, France
[2] Univ Paris 05, Paris, France
[3] Univ Paris 06, Paris, France
[4] Hop Cochin, Dept Pathol, F-75674 Paris, France
关键词
RENAL-CELL CARCINOMA; LYMPHOID STRUCTURES; PROGNOSTIC-FACTOR; CANCER; SURVIVAL; THERAPY; DENSITY; IMPACT; MICROENVIRONMENT; INFILTRATION;
D O I
10.1016/j.coi.2014.01.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A tumour grows in a complex microenvironment composed of stromal cells, lymphoid and myeloid cells, vascular and lymphatic vessels, and the resultant cytokine and chemokine milieu. In most primary tumours, a strong Th1/cytotoxic T cells infiltration correlates with a longer survival. This beneficial effect can be hampered by the presence of M2 polarized macrophages and high VEGF production. Recent studies revealed that the pattern of the tumour microenvironment remains a major prognostic factor even in the metastatic lesions, while been reproducible between the primary and metastatic tumour. Nevertheless the prognostic impact of the Th1/cytotoxic T cell infiltrate could be different according to the origin of the primary tumour. This model highlights a novel tumour cell-dependent immune contexture that predicts patient's clinical outcome and has implications in the use of immunotherapies.
引用
收藏
页码:8 / 15
页数:8
相关论文
共 63 条
[1]   A Decrease of Regulatory T Cells Correlates With Overall Survival After Sunitinib-based Antiangiogenic Therapy in Metastatic Renal Cancer Patients [J].
Adotevi, Olivier ;
Pere, Helene ;
Ravel, Patrice ;
Haicheur, Nacilla ;
Badoual, Cecile ;
Merillon, Nathalie ;
Medioni, Jacques ;
Peyrard, Severine ;
Roncelin, Stephane ;
Verkarre, Virginie ;
Mejean, Arnaud ;
Fridman, Wolf H. ;
Oudard, Stephane ;
Tartour, Eric .
JOURNAL OF IMMUNOTHERAPY, 2010, 33 (09) :991-998
[2]   Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma [J].
Arzumanyan, Alla ;
Reis, Helena M. G. P. V. ;
Feitelson, Mark A. .
NATURE REVIEWS CANCER, 2013, 13 (02) :123-135
[3]   A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CINIII lesions [J].
Bais, AG ;
Beckmann, I ;
Lindemans, J ;
Ewing, PC ;
Meijer, CJLM ;
Snijders, PJF ;
Helmerhorst, TJM .
JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (10) :1096-1100
[4]   Tumor regression in cancer patients by very low doses of a T cell-engaging antibody [J].
Bargou, Ralf ;
Leo, Eugen ;
Zugmaier, Gerhard ;
Klinger, Matthias ;
Goebeler, Mariele ;
Knop, Stefan ;
Noppeney, Richard ;
Viardot, Andreas ;
Hess, Georg ;
Schuler, Martin ;
Einsele, Hermann ;
Brandl, Christian ;
Wolf, Andreas ;
Kirchinger, Petra ;
Klappers, Petra ;
Schmidt, Margit ;
Riethmueller, Gert ;
Reinhardt, Carsten ;
Baeuerle, Patrick A. ;
Kufer, Peter .
SCIENCE, 2008, 321 (5891) :974-977
[5]   The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma [J].
Beck, Andrew H. ;
Espinosa, Inigo ;
Edris, Badreddin ;
Li, Rui ;
Montgomery, Kelli ;
Zhu, Shirley ;
Varma, Sushama ;
Marinelli, Robert J. ;
van de Rijn, Matt ;
West, Robert B. .
CLINICAL CANCER RESEARCH, 2009, 15 (03) :778-787
[6]   Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer [J].
Bindea, Gabriela ;
Mlecnik, Bernhard ;
Tosolini, Marie ;
Kirilovsky, Amos ;
Waldner, Maximilian ;
Obenauf, Anna C. ;
Angell, Helen ;
Fredriksen, Tessa ;
Lafontaine, Lucie ;
Berger, Anne ;
Bruneval, Patrick ;
Fridman, Wolf Herman ;
Becker, Christoph ;
Pages, Franck ;
Speicher, Michael R. ;
Trajanoski, Zlatko ;
Galon, Jerome .
IMMUNITY, 2013, 39 (04) :782-795
[7]   CANCER RISK AFTER RENAL-TRANSPLANTATION IN THE NORDIC COUNTRIES, 1964-1986 [J].
BIRKELAND, SA ;
STORM, HH ;
LAMM, LU ;
BARLOW, L ;
BLOHME, I ;
FORSBERG, B ;
EKLUND, B ;
FJELDBORG, O ;
FRIEDBERG, M ;
FRODIN, L ;
GLATTRE, E ;
HALVORSEN, S ;
HOLM, NV ;
JAKOBSEN, A ;
JORGENSEN, HE ;
LADEFOGED, J ;
LINDHOLM, T ;
LUNDGREN, G ;
PUKKALA, E .
INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (02) :183-189
[8]   AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy [J].
Bower, M ;
Palmieri, C ;
Dhillon, T .
CURRENT OPINION IN INFECTIOUS DISEASES, 2006, 19 (01) :14-19
[9]   Causes of and Prevention Strategies for Hepatocellular Carcinoma [J].
Cabibbo, Giuseppe ;
Maida, Marcello ;
Genco, Chiara ;
Antonucci, Michela ;
Comma, Calogero .
SEMINARS IN ONCOLOGY, 2012, 39 (04) :374-383
[10]   Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence [J].
Camus, Matthieu ;
Tosolini, Marie ;
Mlecnik, Bernhard ;
Pages, Franck ;
Kirilovsky, Amos ;
Berger, Anne ;
Costes, Anne ;
Bindea, Gabriela ;
Charoentong, Pornpimol ;
Bruneval, Patrick ;
Trajanoski, Zlatko ;
Fridman, Wolf-Herman ;
Galon, Jerome .
CANCER RESEARCH, 2009, 69 (06) :2685-2693